Pular para o conteúdo principal
Ranking Invest

SANA - Sana Biotechnology, Inc.

Segmento: HealthcareSana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.

Análise Ranking Invest

Valuation estimado
-16,36%
-$ 812.55 Mi
Valor de Mercado
$ 937.00 Mi
Desconto (AV)-215.3%
IVR
-0.87A companhia vale -0,87 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-1.04O valuation alternativo equivale a -104% do valor de mercado da companhia.
MLL
-1.04O lucro líquido dos controladores em 16 trimestres equivale a -104% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 154.57 Mi

Dívida Líquida

-$ 57.07 Mi

L4T

-$ 211.82 Mi

Indicadores Básicos

ROE

-137.04%

Índices de Previsibilidade

Receita Líquida

A0.00

Lucro

C0.28

Margem

A0.00

Índices de Tendência

Receita Líquida

D0.00

Lucro

C3.96

Margem

D0.00

Índices de Endividamento

DIV/PAT

-0.37

DIV/L4T

0.27

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.